Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals
India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker    Newsletter   Tax Corner NRI Centre Forums E-Mail Chat Masala Feedback
my Last 5 Scrips
Company BSE Price(Rs) % Chg
Tata Stl 506.75 1.60
Bhel 228.45 3.51
Tata Mot 525.60 3.70
Hindalco 163.05 1.56
Tata Pow 88.00 2.86
Clear All Clear Last
Shares
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
Sector Watch
Economy Watch
Snapshot-Sun Pharma Advanced Research Company Limited
Sun Pharma Advanced Research Company Limited
Sector:Pharmaceuticals Pharmaceuticals - Pharmaceuticals - Others
BSE:532872NSE:SPARCBloomberg:SPADV@INReuters:SPRC.BO
Market Lot: 1Face Value: 1ISIN Demat: INE232I01014
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
25-APR-14 Sun Pharma Advanced Research Company announced that Anil Raghavan has been appointed as the chief executive officer of the company with immediate effect. 24-JAN-14 Sun Pharma Advanced Research Company (SPARC) has announced that its licensee has received an approval from the Drug Controller General of India for Paclitaxel Injection Concentrate for Nanodispersion (PICN), indicated for the treatment of metastatic breast cancer. 17-DEC-...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Sun Pharma Advance Research names Anil Raghavan as CEO  -IRIS 25-Apr-14
Previous

More


Brief Financials (in Rs. Mn.) 
Period ending (months)30-Jun-2014(3)31-Mar-2014 (12)31-Mar-2013 (12)
Net sales 358.501670.30872.80
Other Income14.20100.0016.20
Total Income372.701770.30889.00
Cost of goods sold453.501335.401040.40
OPBDIT-80.80434.90-151.40
PAT-97.40303.20-224.90
Gross Block---
Equity capital236.70236.70236.60
EPS (Rs.)-1.28-1.03
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-82.19 - 140.23NA
Debt / Equity (x)---
Operating margin (% of OI)-21.724.6-17.0
Net margin (% of OI)-26.117.1-25.3
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
Sun Pharma Advanced Research Centre
Akota Road
Akota
Vadodara
Gujarat-390 020
PHONE
(0265) 2330 815
FAX
(0265) 2354 897
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | E-mail | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer